Viscoelastic Haemostasis
[Viscoelastic Haemostasis]
EPTIS Ringversuch Nr. 1176653 | Letze Änderung 2024-05-22 | URL: https://www.eptis.bam.de/pts1176653 https://www.eptis.bam.de/pts1176653
| Name des Anbieters | ||||||||||||||||||||||||||||
| Name des Anbieters | Weqas Weqas | |||||||||||||||||||||||||||
| Ansässig in | United Kingdom | |||||||||||||||||||||||||||
| Sprache(n) | ||||||||||||||||||||||||||||
| Anmerkungen | The Programme is aimed at clinical staff using Point of Care (POCT) devices such as the ROTEM Sigma and TEG 6 devices rather than laboratory personnel using Thromboelastometry (ROTEM Delta) or Thromboelastography (TEG) analysers. The Programme assesses the performance of the devices and the clinical teams in correctly identifying the specific parameters used in the treatment and transfusion algorithms for the different clinical pathways. Two Lyophilized human citrated plasma samples (including those enriched with unfractionated Heparin) are distributed every 3 months. The Programme assesses the performance criteria relating to qualitative and quantitative analytes. For quantitative analysis, bias and impression are assessed. This programme is provided in collaboration with the External quality Control of diagnostic Assays and tests foundation in the Netherlands (ECAT). The ECAT foundation is a non-profit organisation providing an international EQA for laboratories working in the field of haemostasis and thrombosis. Samples are shared between the two providers as are the anonymised results. This allows for a larger peer group assessment of the results in this highly specialised field. Key Features: - Working in collaboration with ECAT. - Large peer group assessment. - Suitable for TEG and TEM. - Covers the major analytes used in postpartum haemorrhage, post cardiac surgery and major trauma. - Milan Model 3 analytical performance specifications used. For more information: https://www.weqas.com/services/poct-eqa/viscoelastic-haemostasis/ or contact@weqas.com | |||||||||||||||||||||||||||
| Klassifizierung | ||||||||||||||||||||||||||||
| Produktgruppen |
Health care / medical devices
|
|||||||||||||||||||||||||||
| Prüfgebiete |
Medical analysis
|
|||||||||||||||||||||||||||
| Technische Einzelheiten | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Ringversuchsziele | ||||||||||||||||||||||||||||
| Zielgruppe des Ringversuchs | The Programme is aimed at clinical staff using Point of Care (POCT) devices such as the ROTEM Sigma and TEG 6 devices rather than laboratory personnel using Thromboelastometry (ROTEM Delta) or Thromboelastography (TEG) analysers. | |||||||||||||||||||||||||||
| Relevante Rechtsvorschriften oder Normen | Accreditation by UKAS based on ISO/IEC 17043. | |||||||||||||||||||||||||||
| Weitere Ziele | characterisation of reference materials and validation of testing methods | |||||||||||||||||||||||||||
| Teilnehmerzahl | ||||||||||||||||||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch UKAS auf der Grundlage von ISO/IEC 17043 |
|||||||||||||||||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | ||||||||||||||||||||||||||||
| Kosten | ||||||||||||||||||||||||||||
| Teilnahmegebühr | https://www.weqas.com/participantzone/subscription-charges/ | |||||||||||||||||||||||||||
| Regelmässig durchgeführt | Ja (Frequency: Quarterly. Samples: 2 x 3.0mL. ) | |||||||||||||||||||||||||||
| Der Ringversuch wird durchgeführt seit | 2020 | |||||||||||||||||||||||||||
| Kontaktdaten des Anbieters | ||||||||||||||||||||||||||||
| Anbieter | Kontaktperson | |||||||||||||||||||||||||||
|
Weqas
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Telefon: 44 (0) 2920 314750 Fax: Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Telefon: 44 (0) 29218 32884 Fax: E-Mail: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |
|||||||||||||||||||||||||||
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.